Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>NPS Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript

NPS Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript

Healthcare Sector and Stocks Analysis from Seeking Alpha

Fri, 9 Nov 2012

NPS Pharmaceuticals, Inc. ( NPSP ) Q3 2012 Earnings Call November 9, 2012, 8:30 a.m. ET Executives Susan Mesco – Senior Director, IR and Corporate Communications Dr. Francois Nader – President and CEO Eric Pauwels – CCO Luke Beshar – CFO Analysts David Friedman – Morgan Stanley David Friedman – ...

Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.